TK

Tang Kevin C

Concentrated strategyLong-term holder

Total reported value

$783.0

Reporting period: 2023-09-30 · Number of holdings: 1

TANG KEVIN C disclosed 1 holdings in its latest 13F filing for the period ending 2023-09-30, with total reported value of $783.0 and a quarterly turnover rate of 0.0%.

Personality snowflake

Concentration
100
Portfolio Stability
0
Momentum/Contrarian
50
Sector conviction
0
Diversification
2
Sizing Uniformity

Recent moves

No holding changes this quarter

Holdings Map

New buyAddUnchangedTrim

Top 10 holdings by weight

Full holdings list this quarter

#TickerIssuerAsset SubclassWeightWeight ChangeShares Change4Q Trend
1HRTXHeron Therapeutics INCStock-Other100.00%

Holding changes this quarter

Position changes disclosed by Tang Kevin C for the quarter ending 2023-09-30, including ticker, issuer, weight change, shares change, and action
#TickerIssuerWeight ChangeShares ChangeAction

FAQ

What is Tang Kevin C and what type of investor is it?
Tang Kevin C is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2023-09-30), the firm manages a tracked equity portfolio valued at approximately $783.0, spread across 1 disclosed positions.
What are Tang Kevin C's largest equity positions?
Based on the latest 13F filing, Tang Kevin C's top holdings by market value are: 1. Heron Therapeutics INC (HRTX) — $783.0 (100.0%)
What changes did Tang Kevin C make in its most recent portfolio filing?
No notable portfolio changes were recorded for Tang Kevin C in the most recent quarter. Holdings appear to have remained relatively stable.
What sectors does Tang Kevin C focus on?
Sector breakdown data is not yet available for Tang Kevin C. Check back after the next 13F processing cycle.